BDBM295696 US10112934, Example 5::US10570125, Example 5
SMILES: CN(C1CCN(CC1)S(C)(=O)=O)C(C)(C)C(=O)Nc1cc(no1)C(C)(C)C#N
InChI Key: InChIKey=MMYWZLMTHBKQCI-UHFFFAOYSA-N
Data: 4 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM295696 (US10112934, Example 5 | US10570125, Example 5) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.230 | n/a | n/a | n/a | n/a |
Centrexion Therapeutics Corporation US Patent | Assay Description CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A... | US Patent US10112934 (2018) BindingDB Entry DOI: 10.7270/Q2F191RP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM295696 (US10112934, Example 5 | US10570125, Example 5) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.50E+3 | n/a | n/a | n/a | n/a |
Centrexion Therapeutics Corporation US Patent | Assay Description CB1: CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37°... | US Patent US10570125 (2020) BindingDB Entry DOI: 10.7270/Q21C209H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM295696 (US10112934, Example 5 | US10570125, Example 5) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.230 | n/a | n/a | n/a | n/a |
Centrexion Therapeutics Corporation US Patent | Assay Description CB2: CHO cells expressing human CB2R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37°... | US Patent US10570125 (2020) BindingDB Entry DOI: 10.7270/Q21C209H | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cannabinoid receptor 1 (Homo sapiens (Human)) | BDBM295696 (US10112934, Example 5 | US10570125, Example 5) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
Centrexion Therapeutics Corporation US Patent | Assay Description CHO cells expressing human CB1R (Euroscreen) were plated at a density of 10,000 cells per well in 384 well plates and incubated overnight at 37° C. A... | US Patent US10112934 (2018) BindingDB Entry DOI: 10.7270/Q2F191RP | |||||||||||
More data for this Ligand-Target Pair |